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Background: Over the course of its intraerythrocytic developmental cycle (IDC), the malaria parasite Plasmodium
falciparum tightly orchestrates the rise and fall of transcript levels for hundreds of genes. Considerable debate has
focused on the relative importance of transcriptional versus post-transcriptional processes in the regulation of
transcript levels. Enzymatically active forms of RNAPII in other organisms have been associated with phosphorylation
on the serines at positions 2 and 5 of the heptad repeats within the C-terminal domain (CTD) of RNAPII. We reasoned
that insight into the contribution of transcriptional mechanisms to gene expression in P. falciparum could be obtained
by comparing the presence of enzymatically active forms of RNAPII at multiple genes with the abundance of their
associated transcripts.
Results: We exploited the phosphorylation state of the CTD to detect enzymatically active forms of RNAPII at most
P. falciparum genes across the IDC. We raised highly specific monoclonal antibodies against three forms of the parasite
CTD, namely unphosphorylated, Ser5-P and Ser2/5-P, and used these in ChIP-on-chip type experiments to map the
genome-wide occupancy of RNAPII. Our data reveal that the IDC is divided into early and late phases of RNAPII
occupancy evident from simple bi-phasic RNAPII binding profiles. By comparison to mRNA abundance, we identified
sub-sets of genes with high occupancy by enzymatically active forms of RNAPII and relatively low transcript levels and
vice versa. We further show that the presence of active and repressive histone modifications correlates with RNAPII
occupancy over the IDC.
Conclusions: The simple early/late occupancy by RNAPII cannot account for the complex dynamics of mRNA
accumulation over the IDC, suggesting a major role for mechanisms acting downstream of RNAPII occupancy in the
control of gene expression in this parasite.Background
The malaria parasite Plasmodium falciparum undergoes
a 48 h life cycle from the moment of red blood cell inva-
sion through to the production and release of mature
progeny. In the course of this intraerythrocytic develop-
mental cycle (IDC), the mRNA level for many genes
rises and falls once at a point that correlates with the
time its protein product is needed. Such results have led
to the proposal of a “just in time” model of plasmodial
gene expression in which mRNAs accumulate just as* Correspondence: zbozdech@ntu.edu.sg; msfeatherstone@ntu.edu.sg
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unless otherwise stated.their products are required during the IDC [1] Many fac-
tors affect mRNA levels, including transcriptional initiation,
transcriptional elongation, mRNA processing, mRNA ex-
port, and mRNA stability. While control of Plasmodium
gene expression at the level of transcription has been
demonstrated [2-5], several recent studies provide evi-
dence that post-transcriptional mechanisms must play a
major role as well. For example, P. falciparum shows a
widespread chromatin opening and histone H2A.Z re-
cruitment in the intergenic regions throughout the IDC.
Although this modification has been associated with ac-
tively transcribed chromatin in other species, in Plasmo-
dium falciparum this histone variant is also recruited
early to genes whose transcripts do not appear until muchThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of the basal transcriptional machinery, TBP and TFIIE,
which are broadly recruited to Plasmodium genes regard-
less of corresponding transcript abundance [9]. Moreover,
nuclear run-ons correlated active transcription of some se-
lected genes with the levels of their transcripts across the
IDC. While some loci showed clear positive correlation be-
tween transcriptional activity and mRNA abundance, others
revealed striking discrepancies strongly indicative of post-
transcriptional regulation [10] and consistent with similar
discordances seen in humans [11]. Additionally, transcript
stability has been demonstrated to vary by an average of six
fold between ring and schizont stages, and is correlated
with a progressive loss of RNA degrading enzymes [12].
Last, parasites deficient in the post-transcriptional regula-
tor CAF1 display major shifts in peaks of mRNA accu-
mulation [13]. Such findings are consistent with major
post-transcriptional control during the IDC.
During transcription, many steps of mRNA synthesis
and processing are integrated through the C-terminal
domain (CTD) of the largest subunit of RNAPII (RPB1).
A hallmark of RPB1 in most eukaryotes is the presence
of a repeating heptapeptide motif in the CTD [14]. In
most eukaryotes, the heptad repeat has the consensus
sequence YSPTSPS and is present in many copies ran-
ging from 52 in humans to 26 in Saccharomyces cerevi-
siae. Moreover, the number and sequence of repeats is
highly invariant within and even between species. By
contrast, the CTD of Plasmodium spp. differs by the in-
clusion of a lysine at position 7 of the heptad repeat
(YSPTSPK), contains fewer repeats and shows much
greater variability in repeat number between and within
Plasmodium species [15,16].
Among other modifications, the serine residues at posi-
tions 2 and 5 (and 7 in many organisms), can be phosphory-
lated and intensive effort has gone into trying to understand
the role of these modifications in gene expression. Much at-
tention has focused on the functional consequences of an
unphosphorylated CTD, mono-phosphorylation at position
5 (Ser5-P), and di-phosphorylation at positions 2 and 5
(Ser2/5-P). A long-held model proposes that the enzym-
atic activity of RNAPII is determined by the phosphoryl-
ation status of the CTD. In this model, RNAPII bearing
a hypophosphorylated CTD is enzymatically inert, while
Ser5-P is required for RNAPII to initiate transcrip-
tion, and Ser2/5-P then confers the elongating and highly
processive activity of RNAPII [14]. However, a revised
model suggests that the phosphorylation status of the
CTD may simply be a correlative marker of RNAPII
activity [17]. Thus, while the exact functions of phos-
phorylation events at the CTD are a matter of debate, there
is a strong consensus that the presence of Ser5-P and es-
pecially Ser2/5-P are marks of transcriptionally active
polymerase.We have exploited the phosphorylation state of the
RNAPII CTD to assess the engagement of most P. fal-
ciparum genes with the transcriptional machinery across
the IDC. This allowed us to assess the extent to which
RNAPII occupancy correlates with the mRNA accumula-
tion. Our data indicate that P. falciparum genes are divided
into two classes depending on whether peak RNAPII bind-
ing occurs early or late during the IDC. When comparing
RNAPII occupancy to mRNA abundance, we identified
subsets of genes with high occupancy and relatively low
RNA levels and vice versa. We find that genes at which
RNAPII is detected early (8 to 32 hours post-infection
(hpi)) are shorter in length, have more introns and shorter
first exons when compared to genes at which RNAPII is de-
tected late (40-48 hpi). Furthermore, we find distinct RNA-
PII occupancy patterns for the early and late genes along
the gene length. Comparison of RNAPII occupancy with
various histone modifications identifies chromatin changes
that precede, accompany and follow RNAPII recruitment.
Together our results show that occupancy by presumed ac-
tive forms of RNAPII cannot account for the highly orches-
trated pattern of mRNA accumulation and loss over the
IDC. We suggest that post-initiation mechanisms such as
transcriptional elongation and mRNA stability may play
predominant roles in determining the dynamics of mRNA
abundance during infection of red blood cells.
Results
Production of monoclonal antibodies specific for three
forms of the CTD of the large subunit of RNAPII
Steps in the generation and use of monoclonal anti-
bodies in this study are summarized in Figure 1A. To
examine the genome-wide distribution of RNAPII, we
raised highly specific monoclonal antibodies against
three forms of the P. falciparum RPB1 CTD: unmodified
CTD, Ser5-P-bearing CTD, and CTD having the Ser2/5-P
double phosphorylation. The phosphorylated forms of
RPB1 have been associated with RNAPII molecules that
are functionally engaged with bound genes. Unphosphory-
lated heptad repeats may be associated with inert forms of
the polymerase, but could also be present as one or more
copies within a CTD that also contains phosphorylated
motifs. The specificity of the antibodies was confirmed in
several ways. First, the antibodies showed high specificity
in ELISA by serial dilution (data not shown) and, second,
by competition with the immunizing peptide in a peptide
competition assay (Figure 1B-D). These results establish
that each antibody specifically recognizes its cognate pep-
tide and not the other two. Third, the appropriate sized
band for P. falciparum RBP1 is also observed on Western
blot of nuclear lysates following immunoprecipitation
using each of the three monoclonal antibodies (Figure 1E).
A well-characterized commercially available antibody
(8WG16) that recognizes unphosphorylated and Ser5-P
Figure 1 Validation of monoclonal antibodies against RNA polymerase II. (A) Schematic of the work flow. P. falciparum samples were
harvested every 8 h across the 48 h life-cycle at time points (TP) 1 through TP6. The same culture was used for triplicate ChIP-on-chip and
transcriptome analyses. (B–D) Peptide competition assays. Monoclonal antibodies were raised against peptides corresponding to the unmodified
heptad repeat (anti-CTD), the heptad repeat monophosphorylated at position 5 (αSer5-P) and diphosphorylated at positions 2 and 5 (αSer2/5-P).
Each monoclonal antibody was pre-incubated with each of the three immunogenic peptides derived from the RNAPII CTD. Reactivity
against the immunizing peptide was then tested by ELISA. The concentration of competing peptide in μg/ml is given to the right of
each graph. (E) Parasite nuclear protein lysate from an asynchronous culture was immunoprecipitated (IP) with each of the three monoclonal
antibodies raised in this study or a non-specific IgG control. The precipitates were separated by 6% SDS-PAGE and Western blot (W) performed with
the indicated antibodies. The appropriately sized band for P. falciparum RPB1 (279 KDa) was observed with all three antibodies (arrowhead). Two panels
are shown for antibody α-Ser2/5-P and represent the same Western blot following a moderate and more extensive (W*) series of washes. Note that
the only significant specific band is of the correct molecular mass for RPB1. No specific bands are detected by the α-CTD and α-Ser2/5 antibodies
following IP with control IgG. The commercial anti-CTD antibody 8WG16 detects a band of the correct molecular mass for P. falciparum RPB1 along
with several faster running species. The positions of the marker bands in KDa are given to the right of the panels they describe.
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sponding to RPB1 in a Western blot of cell lysate. Al-
though all antibodies (including 8WG16) detect additional
bands, stringent washing leaves a unique band corre-
sponding to the expected molecular weight of RPB1 as the
major species detected by the αSer2/5-P antibody (indi-
cated by W* in Figure 1E). Fourth, IP followed by mass
spectrometry revealed that both the αSer5-P and αSer2/5-
P antibodies precipitated RPB1 as well as two additional
subunits of RNAPII, namely RPB2 and RPB3, with high
confidence. No RNAPII subunits were precipitated by a
control IgG (Additional file 1: Table S1). Together, these
results show that these antibodies are specific for the
CTD of RPB1 in P. falciparum and are suitable for use in
the chromatin immunoprecipitation assay (ChIP).
RNA polymerase II shows a bi-phasic binding distribution
across the P. falciparum IDC
We next used these P. falciparum anti-RNAPII antibodies
in ChIP-on-chip analysis to map the position and enzymaticFigure 2 ChIP-on-chip reveals two classes of genes distinguished by rec
phaseograms (blue-yellow scale) representing temporal occupancy patterns f
CTD, Ser5-P and Ser2/5-P. The data were filtered to include only those loci whe
across the life cycle. The yellow-blue color scale represents the mean-centered l
prominent probe clusters binding the Ser2/5-P form of RNAPII early vs late in th
(green-red scale) depicts the phase of peak gene expression for the P. falciparum
two classes of genes distinguished by enrichment in RNAPII binding either early
PCR was carried out on representative genes chosen from the early (B) and late
across the IDC. Primers for real time PCR were designed to amplify 200–300 bp
time points T1 to T6 and the y-axis shows the fold change. Solid lines represe
(ChIP-on-chip) profile at the same probe region. The fine dotted line represen
of cDNA to the microarrays. Error bars show standard deviation of triplicate dstatus of RNAPII across the entire P. falciparum genome
over the 48 h of the IDC at 8 h intervals. The commercial
anti-CTD antibody, 8WG16, was also used in parallel.
We used custom-made microarrays spotted with 70-mer
oligonucleotides covering both coding and intergenic
regions [19,20].
Following hybridization and analysis of the microarrays,
we selected all those probes exhibiting a significantly oscil-
lating profile with p <0.05 and ≥1.5 fold change across
the life cycle. This cut-off resulted in the retention of a
subset of probes for each of the three antibodies: 2,936
probes with the αCTD (unphosphorylated) antibody; 4,462
probes with the αSer5-P antibody; and 4,255 probes with
the αSer2/5-P antibody. We addressed the temporal order
within the dataset by creating a phaseogram of RNAPII oc-
cupancy. The genome-wide profiles reveal a striking peri-
odicity involving the majority of genes (Figure 2A). Most
genes can be divided in two groups: those that bind
RNAPII early during the IDC and those that bind RNAPII
late, regardless of the phosphorylation state of the CTD.ruitment of RNAPII either early or late in the IDC. (A) Three
or the three forms of RNAPII detected in this study: unphosphorylated
re RNAPII shows an oscillating profile with p <0.05 and a fold change ≥1.5
og transformed ratios of ChIP/input values across the IDC (T1 to T6). Two
e IDC are marked with orange rectangles. The phaseogram on the far right
transcriptome across the IDC. (B-C) ChIP-qPCR confirms the presence of
or late in the IDC. Using immunoprecipitated DNA, quantitative real time
(C) categories to validate the ChIP occupancy profiles of Ser2/5-P RNAPII
regions around the respective probe on the microarray. The x-axis gives
nt real time PCR profiles, whereas dashed lines give the microarray
ts the mRNA levels across the six time points determined by hybridization
eterminations. See also Additional files 2, 3 and 4: Figures S1, S2 and S3.
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the Ser2/5-P form of RNAPII which is the elongating form
of the polymerase. The data show a striking switch be-
tween T4 (32 hpi) and T5 (40 hpi) such that the Ser2/5-P
form binds maximally to one large fraction of genes early
in the IDC until T4 (1,600 genes), but then switches to a
largely mutually exclusive set of genes late in infection
during T5 and T6 (1,359). Only 11% of genes are present
in both categories due to differential signals from probes
within the same gene. A similar observation is made for
data sets obtained with the other two antibodies against
the unmodified CTD and the Ser5-P; however, the switch
between early and late binding profiles for these two forms
occurs earlier between T3 (24 hpi) and T4 (32 hpi). Differ-
ential occupancy of the different forms of RNAPII argues
against a bias inherent to the experimental procedure or
the microarrays themselves. Importantly, ChIP-on-chip
with the commercial 8WG16 antibody likewise revealed a
segregation of early vs late signals for the majority of probes
in a pattern resembling those obtained with the α-CTD
and α-Ser5-P antibodies (Additional file 2: Figure S1A).
This is consistent with the demonstration that 8WG16
recognizes the unmodified and Ser5-P forms of the heptad
repeat [18]. Hierarchical clustering of the datasets also
highlights the distinct distribution of RNAPII in just two
prominent groups, one dominated by loci where RNAPII
binds early in the IDC and another dominated by loci
where the binding is late (Additional file 2: Figure S1A and
Additional file 3: Figure S2). The timings of the switches
are identical to those revealed in the phaseograms.
To confirm results obtained by microarray, we per-
formed ChiP-qPCR at each of the six time points for six
genes that bind the elongating (Ser2/5-P) form of RNAPII
early in the IDC and four that bind late. Although qPCR
reveals a greater dynamic range than the microarray
analysis, the results show that all early genes acquire
peak RNAPII recruitment early in the IDC at either time
point 3 or 4 (24 and 32 hpi), while late genes do not dis-
play maximal RNAPII binding until time point 6 (48 hpi)
(Figure 2B,C). These findings strongly validate the results
of ChIP-on-chip and confirm the presence of two gene
classes distinguished by early or late enrichment in RNA-
PII binding over the course of the IDC.
Relationship between transcriptional activity and mRNA
abundance
To characterize the relationship between the genome-wide
binding of distinct forms of RNAPII and mRNA abun-
dance, we calculated the Pearson’s Correlation Coefficient
(PCC or r) between the dynamic RNAPII occupancy
(p <0.05 and 1.5 fold change) and the expression levels
of corresponding mRNAs. We established two subsets
(Figure 3). In one subset, increased RNAPII occupancy
(yellow) was positively correlated with high mRNA levels(red). In the other subset, the correlation was negative,
meaning that there was either high mRNA expression
without detectable RNAPII binding, or that we observed
RNAPII binding without corresponding mRNA expres-
sion. With respect to the Ser2/5-P isoform of RNAPII,
1,740 probes were highly positively correlated with gene
expression (right panel), while 1,200 probes were strongly
negatively correlated (left panel) (Figure 3C). Similar ob-
servations were also made with the unmodified CTD
and Ser5-P isoforms of RNAPII (Figure 3A,B) as well
as with the 8WG16 commercial antibody (Additional
file 2: Figure S1B). Approximately a third of the probes
showed no significant correlation. The above results thus
reveal four subsets of genes with respect to RNAPII occu-
pancy and mRNA abundance: genes which bind RNAPII
early and are either positively or negatively correlated with
mRNA levels (early/positive and early/negative), and genes
which bind RNAPII late (late/positive and late/negative).
We assessed the genomic characteristics of RNAPII-
Ser2/5-P-associated early and late genes. We mapped the
genes that showed either early or late binding of RNAPII
Ser2/5-P onto the 14 P. falciparum chromosomes. All chro-
mosomes were seen to bear potential clusters (Additional
file 4: Figure S3); however, closer examination revealed
that genes within such clusters do not share a com-
mon expression profile, arguing against any functional
organization and consistent with a previous study sug-
gesting that P. falciparum lacks chromosomal domains
with common expression profiles [1]. We mapped several
genomic descriptors known to associate with gene expres-
sion regulation in human [21], including gene length, GC
content, number of introns and intron length. We found
that genes binding RNAPII Ser2/5-P at early times (T1 to
T4) are short with lower GC content by comparison to
late genes (T5 and T6) which are significantly longer
(Additional file 5: Figure S4A, B). In addition, the early
genes had a greater number of introns when compared
to late genes (Additional file 5: Figure S4C; see below).
The presence of introns has been linked to higher transcrip-
tional efficiency [22]. We assessed the length of the first
exon and found that late genes have longer first exons when
compared to early genes (Additional file 5: Figure S4D).
Thus, early-transcribed genes are shorter in length, have
more introns and shorter first exons. Short gene length
and short first exons are properties of highly expressed
genes in human cells [23,24].
Differential distribution of RNAPII along the transcription
unit distinguishes genes binding RNAPII early vs late in
the IDC
According to one model of CTD function, phosphoryl-
ation of Ser5 residues predominates near the promoter,
whereas toward the end of the gene RNAPII is extensively
phosphorylated on Ser2 residues [25,26]. To explore the
Figure 3 (See legend on next page.)
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Figure 3 Relationship between RNAPII occupancy and mRNA abundance. Correlation between the genome-wide detection of unmodified
CTD (panel A), Ser5-P (panel B) and Ser2/5-P (panel C) forms of RNAPII and mRNA levels was calculated using Pearson’s correlation coefficient
(PCC) between the mean-centered profile of all probes with p <0.05 and the corresponding gene transcripts. The data have been presented as
bar graphs with bins of PCC ranging from −1 to +1 on the x-axis plotted against the number of probes falling into each bin on the y-axis. The
phaseograms in the right-hand panels represent probes which are highly positively correlated with gene expression (r ≥0.4), and in the left-hand
panels display probes showing negative correlation with gene expression (r ≤ -0.4). One-third of the probes do not show any correlation. The
order of the probes represented in the phaseograms for RNAPII binding is the same as those used in the mRNA phaseogram. On the basis of this
analysis, we identify four subsets of genes with respect to the correlation between RNAPII binding and mRNA abundance. These are early/positive
(RNAPII binds early in the IDC and is positively correlated with mRNA levels), early/negative and late/positive and late/negative.
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along the transcription unit, we examined the distribution
of the three forms of RNAPII along the gene for each of
the four classes, namely early and late binders that posi-
tively correlated with the mRNA levels (Figure 4A, right
panels) and early and late binders that negatively corre-
lated with mRNA levels (Figure 4A, left panels). We ob-
served very distinct profiles for genes that show a positive
correlation between mRNA levels and peak RNAPII bind-
ing either early or late in the IDC. Promoter regions in
P. falciparum are predicted to lie between 300 and 1650
bp upstream of the ATG [27]. RNAPII accumulates in the
promoter region of early binders, whereas for late binders
RNAPII is enriched in the gene body (Figure 4A, right
panel). Likewise, the Ser2/5-P form of RNAPII was con-
centrated within upstream presumptive promoter regions
(–1,000 to –500) of genes expressed early and negatively
correlating with mRNA levels (Figure 4A, left panel). On
the other hand, the unmodified (CTD) and Ser5-P forms
did not obviously follow this distribution. A goodness-of-
fit test assigns a significant p value (<0.01) to the differ-
ence in RNAPII distribution (all three forms) between
early and late binders (Figure 4B,C) suggesting that the
transcriptional process in early vs late phases may be dis-
tinguished by mechanistic differences. However, it is pos-
sible that this has more to do with the transcription of
shorter vs longer genes or the coupling of the splicing ma-
chinery to the CTD, since “late” genes are longer and have
fewer introns, as noted above.
To determine whether the observed differential recruit-
ment of RNAPII at early vs. late times of infection also re-
flects functional gene classes, we mapped early and late
genes to known pathways and determined which pathways
are over-represented in each group by using three pathway
databases, namely Gene Ontology (GO), Kyoto Encyclopedia
of Genes and Genomes (KEGG) and Malaria Parasite
Metabolic Pathway (MPMP) (Figure 4D). We found that
early genes were significantly enriched at loci associated
with growth (ribosome structure and maturation), metab-
olism (starch and sucrose metabolism, purine and pyrimi-
dine metabolism), and transcription and splicing. As
expected, late genes were significantly enriched in proteins
involved in host-parasite interactions and pathogenesis(merozoite invasion and motility, merozoite surface pro-
teins) and cytoskeleton organization and biogenesis.
Relationship between RNAPII occupancy and chromatin
modifications
Our group and others have shown that chromatin influ-
ences gene expression in P. falciparum [6,19,28-34]. To
examine the relationship between RNAPII occupancy and
chromatin modification, we calculated the PCC (r) be-
tween dynamic RNAPII occupancy of unmodified CTD,
Ser5-P and Ser2/5-P and 13 histone modifications deter-
mined in our previous study [19]. We identified 5 histone
marks including H3K9ac, H3K56ac, H4ac4, H4K12ac and
H4K20me1 which showed clear positive correlation with
Ser2/5-P RNAPII binding at high statistical confidence
(Figure 5). All these histone modifications, in addition to
H3K4me3, associate with transcriptionally active protein
coding genes and are described as active marks [30,31,33],
and references therein.
To determine whether some histone modifications
may precede or follow RNAPII recruitment, we calcu-
lated the PCC (r) between RNAPII occupancy (all three
forms) and histone modification occurring 8 h before or
after recruitment (Figure 6). For example, recruitment of
each form of RNAPII at T2 (16 hpi) was assessed rela-
tive to histone modifications occurring 8 h earlier at T1
(8 hpi), and 8 h later at T3 (24 hpi), and so on for all six
time points. For all forms of RNAPII, we found that some
histone marks precede, accompany or follow RNAPII re-
cruitment. Thus, the activating histone mark H3K9ac
precedes (and accompanies) recruitment of all forms of
RNAPII (Figure 6A-C). Other marks are specific for one
or more of the RNAPII isoforms. Thus, H4K16ac, a mark
of actively transcribed euchromatin [35], and H4K5ac
which has been shown to “bookmark” genes for rapid acti-
vation [36], show clear positive correlations with subse-
quent recruitment of the Ser2/5-P form of RNAPII
(Figure 6C). By contrast, both H3K4me3 and H4R3me2
show positive correlation with these histone modifications
following recruitment of Ser2/5-P RNAPII. Conversely,
H4R3me2, associated with repression of gene expression
[37,38], shows clear negative correlation with subsequent
recruitment of all forms of RNAPII (Figure 6A-C), while
Figure 4 (See legend on next page.)
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Figure 4 Distribution of RNAPII along the gene length and enriched pathways. (A) The plots represent the average distribution along the
gene of probes (with p <0.05) associated with each form of RNAPII. The start codon is taken as “0”. Data are organized into bins ranging from
-500 bp upstream of the ATG to +4000 bp downstream and plotted against the percentage of total probes falling into each bin. The position of
a probe along the x axis is the average of the positions of all probes within a given bin. While all genes are aligned at the ATG (“0”), they terminate
at a wide range of positions downstream with an average at +2.5 kb. The plots on the right show the distribution of early/positive and late/positive loci
(r >0.4), while those on the left plot the distribution of early/negative and late/negative loci (r <0.4). (B-C) The plots represent the average distribution
of the genetic loci associated with each form of RNAPII as a function of gene length. Position distributions were plotted as histograms for each gene
group with intervals of 500 bp from -2 kb to +5 kb. Histograms were plotted to display the binding positions in 500 bp intervals from -2 kb to 5 kb
flanking the translational start codon at 0. A goodness-of-fit test was performed within each bin to calculate the probability of that region being
equally bound by RNAPII for different gene groups. Regions with binding bias by group were assigned p <0.05 using the chi-square test. Data were
assessed in this manner for (B) early/positive and late/positive and (C) early/negative and late/negative subsets. (D) Functionally enriched pathways
(p <0.05) for each of the four gene groups. Colors refer to the three distinct databases that were used for pathway enrichment analysis.
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RNAPIISer2/5-P form (Figure 6C). Both the positive and
negative correlations are highly statistically significant by
the Kolmogorov-Smirnov test (p <0.001). Other histone
modifications were not seen to anticipate or follow RNA-
PII recruitment (Additional files 6, 7 and 8: Figure S5, S6
and S7).
Discussion
In this study, we performed genome-wide mapping of
RNAPII occupancy over the 48 h of the IDC using a
ChIP-on-chip approach. We used three highly specific
monoclonal antibodies against different forms of the P.
falciparum RBP1 CTD in addition to 8WG16, a well-
characterized commercial monoclonal antibody raised
against wheat germ RNAPII and likewise recognizing
the CTD [18,39]. All four antibodies gave highly similar
results. We observed that the parasite’s IDC is divided
into early and late phases of RNAPII occupancy. Max-
imal binding by the forms of RNAPII bearing unmodi-
fied and Ser5-P modified heptads (recognized by α-CTD,
α-Ser5-P and 8WG16) switches from one large set of
genes to another between T3 (24 hpi) and T4 (32 hpi),
while that of the Ser2/5-P form does so between T4 and
T5 (40 hpi). This is the first indication of which we are
aware that the Plasmodium life cycle is divided into ra-
ther stark early vs. late stages defined by a component of
the transcriptional machinery.
Considerable controversy has surrounded the role of the
CTD heptad repeats and their phospho-serines. While the
heptad repeats are necessary for the survival of yeast and
human cells, they are dispensable for transcription in vitro
[40]. In addition, the loss of Ser2 phosphorylation does
not affect the transcription of the majority of genes in fis-
sion yeast, while the budding yeast kinase Kin28p is not
required for transcription but rather to couple transcrip-
tion initiation to the capping process [40]. These and
other observations have led to the suggestion that the hep-
tad repeats are not required for transcription per se, but
rather to bind and coordinate the activity of proteins
exerting co-transcriptional functions such as capping andsplicing [17]. Apicomplexans are within the branch of eu-
karyotes stemming from an ancestor bearing CTD heptad
repeats. However, the severe reduction in repeat number
in basal Plasmodium species suggests that heptad repeats
were first lost in Plasmodium spp and then re-acquired in
primate-infecting lineages [15,16]. This raises the possibil-
ity that the heptad repeats of P. falciparum play roles en-
tirely unrelated to those of their counterparts in other
species, or at least unrelated to transcriptional processes.
This seems unlikely for several reasons. First, P. falciparum
encodes an almost complete set (13 of 14) of so-called core
CTD-interacting proteins with major transcriptional func-
tions [41]. Second, P. falciparum encodes a clear homolog
of the yeast Ctk1 kinase in part responsible for Ser2 phos-
phorylation (PF3D7_0417800) [41,42] and another kinase
displaying striking similarity to human CDK7 responsible
for phosphorylation at Ser5 (PF3D7_1014400; E =3e-76 by
BLASTP). Third, as revealed by our antibodies, both ser-
ines 2 and 5 of the P. falciparum CTD are phosphorylated
in vivo. Fourth, an alternative register and alignment of the
functional heptad unit suggests that basal Plasmodium
species may harbor more units of full and partial heptads
than previously appreciated [43], suggesting that interac-
tions between the CTD and its partners were never lost in
these organisms. Fifth, the evolution of exclusively new
functions for the CTD should be accompanied by the evo-
lution of a new motif, not the same heptad motif already
implicated in earlier functions. Together, these observa-
tions argue that the evolution of a completely new set of
functions for the heptad repeats is less parsimonious than
the re-establishment (or enhancement) of interactions with
partners previously selected in the course of evolution.
The above argument does not preclude, however, that the
P. falciparum CTD may have also acquired novel functions
and interaction partners.
At a minimum for the interpretation of our results, it
seems reasonable to expect that the presence of phosphor-
ylated serines in the CTD is indicative of RNAPII that is
actively engaged in transcription. We find a similar distri-
bution of RNAPII bearing unmodified and phosphorylated
heptads. Similar observations have been made by several
Figure 5 (See legend on next page.)
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Figure 5 Relationship between RNAPII occupancy and chromatin modification. (A-C) Distribution of correlation between the binding of the
three forms of RNAPII and 13 different histone mark occupancy profiles for ChIP-enriched probes showing an oscillating profile with p <0.05
and ≥1.5 fold change across the IDC. Correlation distributions were plotted as histograms for each histone modification, with bins of PCC ranging
from −1 to +1 plotted against the fraction of probes falling into each bin (the number of probes falling into each bin over the total number of
probes assessed) for random vs. observed distributions. A Kolmogorov-Smirnov test was applied to compare observed and random correlations,
and the statistical significance (p) of the observed distribution can be seen at the bottom of each graph. Modified degree of skewness (S) of the
PCC distribution is given on the bottom right of each graph (see Methods). See also Additional files 5, 6 and 7: Figures S4, S5 and S6.
Figure 6 Statistically significant correlations between RNAPII binding and histone modification. Binding of the (A) unmodified (CTD),
(B) Ser5-P and (C) Ser2/5-P forms of RNAPII was correlated (PCC) with 13 histone modifications present either 8 h earlier (-8 h) or 8 h later (+8 h)
than RNAPII binding. A two-sample Kolmogorov-Smirnov test was applied to each pair of data to test whether the function of correlations
between RNAPII occupancies and histone modifications were less or greater than the function of similar correlations after 8 h shift in RNAPII or
histone modification profile. For each histone modification, a mode of correlation (mc) greater than 0.4 is shown in yellow, whereas an mc less
than -0.4 is in blue. A white square denotes no correlation. The correlations derived from comparison within the same time point (0 h; see
Figure 5) are included for convenience. Only statistically significant correlations are shown.
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one or more unmodified heptads in the company of other
phosphorylated repeats within a CTD [17]. Because all the
antibodies used in this study find their epitopes in the
CTD, it remains possible that we have failed to detect
RNAPII sub-populations bearing alternative modifications
of this domain. The use of an anti-RNAPII antibody di-
rected against a domain that is not subject to extensive
modification and which is evolutionarily stable would there-
fore provide a useful complement to our results.
It may be particularly insightful to compare our results
with those of two previous studies. One report used the
nuclear run-on assay to assess the engagement of RNAPII
at several genes across the IDC [10]. Strikingly, some
genes showed an inverse correlation between RNAPII en-
gagement and mRNA levels, consistent with our early-
negative and late-negative categories in which RNAPII
binding, or lack thereof, is not reflected in mRNA levels.
In another study, ChIP was used to assess the recruitment
of the general transcription factors TBP and TFIIE to a
number of genes at both ring (12 – 14 hpi) and trophozo-
ite (32 - 34 hpi) stages (roughly equivalent to our T2 and
T4, respectively). Regardless of whether these genes were
ring-specific or trophozoite-specific, both TBP and TFIIE
were present at these genes at both ring and trophozoite
stages [9]. These findings are consistent with our observed
discordance between occupancy by RNAPII and the
mRNA levels for a large subset of genes. However, whereas
we find that the parasite genome is largely divided between
those genes that recruit RNAPII early vs late, TPB and
TFIIE were found in both rings and trophozoites at genes
that are expressed at only one of these stages. At first, these
results may seem contradictory, since TFIIE binding is
expected to follow RNAPII recruitment [44]. However, as
described in yeast, a promoter that has undergone one
round of transcriptional initiation remains bound to a
complex of general transcription factors referred to as the
scaffold or re-initiation complex. The scaffold includes
TBP and TFIIE, but not RNAPII, and has been proposed
to prime the promoter for re-initiation [45]. It is there-
fore possible that many erythrocyte-expressed genes of
P. falciparum are primed for re-initiation by a TBP- and
TFIIE-containing scaffold, ready for RNAPII recruitment
in response to appropriate cues. Two of the genes analyzed
for TBP and TFIIE binding are included in our data set.
msp1 (PFI1475w/ PF3D7_0930300) and rhoph3 (PFI0265c/
PF3D7_0905400) bind TBP and TFIIE at both ring and
trophozoite stages [9]. By contrast, we observe RNAPII
occupancy at these two genes only late in the IDC: the
presence of the unmodified CTD form at msp1 and the
presence of the Ser5-P form at rhop3 is not observed until
T4 (trophozoite stage). Both genes then associate with the
Ser2/5-P form by T5. Thus, the appearance of enzymati-
cally active forms of RNAPII follows that of TBP andTFIIE, at least in these instances. This is consistent with
the presence of TBP and TFIIE in a scaffold-like complex
ready for efficient RNAPII recruitment when the time is
right.
Our data show that RNAPII occupancy and the corre-
sponding mRNA levels of many genes are well correlated,
suggesting that the control of transcription is often a de-
terminant of gene expression. Surprisingly, however, a
large number of genes achieve significant mRNA levels
only several hours following their peak RNAPII Ser2/5-P
occupancy (early/negative and late/negative), suggesting
that transcription is not a rate-limiting step at these loci.
One possibility is that RNAPII is “pre-loaded” onto such
genes but kept in a paused (or poised) state. Although
RNAPII levels subsequently fall as mRNA levels rise, this
may be due to the greater transcriptional activity of fewer
polymerase molecules. This would then place a major
regulatory control in P. falciparum at the point of tran-
scriptional elongation as has been well documented in
other eukaryotes [46]. If so, the parasite must have evolved
mechanisms to stall RNAPII despite the presence of the
Ser2/5-P modification at the CTD since this form of the
polymerase, just as for the unphosphorylated and Ser5-P
forms, is enriched at a subset of genes at times when their
mRNA levels are low. The dispensability of Ser2 phos-
phorylation for the expression of most genes in fission
yeast is consistent with this notion [47]. Non-exclusively,
abundant mRNA despite decreased levels of RNAPII
binding could be due to a switch from labile to stable tran-
script states, consistent with previous studies demonstrat-
ing a large increase in transcript stability over the course
of the IDC [12].
The highly similar distribution along the gene length
of all forms of the polymerase studied here may be con-
sistent with this notion. On the other hand, the apparent
distribution of CTD isoforms along the gene in other or-
ganisms varies greatly depending on the antibody in use
and the presence/absence of modifications adjacent to
the epitope (summarized and extended in [17]). From this
perspective, the distributions observed in this study may
not be surprising. The Ser2/5-P form of RNAPII – some-
times described as the elongating form – is enriched up-
stream of the coding region of “early” genes. While this
may be surprising, a similar distribution for RNAPII phos-
phorylated at Ser2 of the heptad repeat has been observed
for a class of genes in Schizosaccharomyces pombe [47].
The division of the IDC into early and late phases as evi-
denced by RNAPII occupancy profiles is paralleled by the
binary changes (open/closed) in chromatin structure that
occur during the parasite’s life cycle [48] whereby the
chromatin opens at the early ring stage, reaching a max-
imum at the trophozoite stage followed by tight packing
in schizonts. The late recruitment of RNAPII addresses
the apparent contradiction that the parasite chromatin is
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late-stage mRNAs. Although some mRNAs detected in
the schizont stage could be regulated at the level of sta-
bility, our results show that RNAPII recruitment does
take place toward the end of the IDC, though restricted
mostly to loci involved in late-stage-specific processes
such as pathogenesis, merozoite maturation and invasion.
Elucidation of the molecular determinants of this early-
late transcriptional switch should provide important in-
sights into fundamental aspects of transcriptional control
in P. falciparum.
We previously carried out genome-wide mapping of
13 histone modifications and correlated their presence
at particular genes with transcript accumulation over the
IDC. In particular, H4K8ac was tightly linked to mRNA
levels and accompanied a promoter inserted at an ec-
topic site in the genome [19]. Here, we further corre-
lated these histone modifications to RNAPII recruitment
and to time points both 8 h earlier and later. The results
reveal distinct chromatin signatures preceding, following
and at the time of binding of distinct forms of RNAPII.
Such signatures may reflect the action of the machinery
used in RNAPII recruitment and maturation, but do not
obviously provide insights into the mechanism control-
ling the early/late switch. Interestingly, we did not find a
correlation between the peaks of H4K8ac modification
and RNAPII binding. And while we do observe a correl-
ation between the binding of the Ser2/5-P form of RNAPII
and H3K4me3, maximal levels of this histone mark only
follow maximal binding by RNAPII Ser2/5-P. Others have
also noted that H3K4me3 is not correlated with transcript
levels [6]. These differences in the timings of H4K8ac and
H3K4me3 modification, peak mRNA levels and maximal
recruitment of RNAPII Ser2/5-P are not consistent
with a simple coordinated process of RNAPII binding
and transcription immediately facilitated by chromatin
modification and leading to increased mRNA output,
and further substantiate a role for post-initiation and
post-transcriptional processes in the control of gene
expression in P. falciparum.
Conclusions
The striking contrast between the relatively simple pattern
of RNAPII recruitment (early vs late) to approximately
two thirds of genes versus the highly orchestrated rise and
fall of their transcripts across the IDC suggests that mech-
anisms downstream of transcriptional initiation may play
a predominant role in the control of gene expression in P.
falciparum. The recent demonstration that the negative
regulation of a var gene subgroup in P. falciparum is me-
diated by a transcriptionally coupled RNase is consistent
with this notion and may have broader implications for
gene expression in this species more generally [49]. Lim-
ited control at the level of transcription initiation, thoughrare, would not be unique to malarial parasites. A closely
related family of protozoan parasites, trypanosomatids,
shows no evidence of developmental control of RNA poly-
merase II transcription [50]. A bias toward post-initiation
regulation of gene expression may have been facilitated by
the homeostatically controlled environments within hu-
man and insect hosts, thereby relieving selective pressure
for the retention of fine control at the level of transcrip-
tion initiation.
Methods
Ethics approval and informed consent
This research involved the use of human blood drawn from
healthy volunteers by trained healthcare professionals and
was approved by the NTU Institutional Review Board and
assigned the IRB approval number IRB-2013-07-020. In-
formed consent was obtained and documented by the sign-
ing of an approved informed consent form.
Generation of monoclonal antibodies
Peptides based on the heptad repeat of the P falciparum
RNAPII CTD and bearing (1) no phosphate (CTD)- Biot-
Ahx-YSPTSPKYSPTSPK and CYSPTSPKYSPTSPK (2) a
phosphate at Ser5 (Ser5-P)-Biot-Ahx-YSPTSPKYSPTSPK
and CYSPTSPKYSPTSPK or (3) phosphates on Ser2 and
Ser5 (Ser2/5-P)- Biot-Ahx-YSPTSPK and CYSPTSPK
were used to immunize BALB/c mice. Serine residues in
bold typeface were phosphorylated. All three peptides
were coupled with Keyhole Limpet Haemocyanin (KLH)
using a Imject® Maleimide Activated mcKLH kit. The
immunization schedule included a first subcutaneous in-
jection of KLH-coupled peptide resuspended in complete
Freund’s adjuvant (CFA, Sigma, St. Louis, USA) followed
by a second subcutaneous injection in incomplete Freund’s
adjuvant (IFA, Sigma) 6 weeks later. Eight weeks after the
first immunization, mice were sacrificed and draining
lymph nodes collected. Isolated lymph node cells were
fused with SP2/0 myeloma cells using polyethylene glycol
(Sigma, St. Louis, USA) according to standard fusion pro-
tocols [51]. Cells were resuspended in HAT medium
(Sigma), distributed in 96-well plates and wells containing
single hybridoma clones were screened by ELISA. All
hybridomas testing positive were further subcloned by
limiting dilution and retested by ELISA for positivity.
N-terminally biotin-tagged peptides were used for appli-
cation to streptavidin coated plates for ELISA (Pierce).
Positive hybridoma clones were expanded in roller bottles
and the corresponding monoclonal antibody was purified
from the culture supernatant via a GammaBind Plus
Sepharose (GE HealthCare Life Sciences).
Peptide competition assay
Phosphorylated and non-phoshorylated peptides were
incubated in a range of concentrations with monoclonal
Rai et al. BMC Genomics 2014, 15:959 Page 14 of 18
http://www.biomedcentral.com/1471-2164/15/959antibodies α-CTD, α-Ser5-P and α-Ser2/5-P at room
temperature for 30 min. The peptide antibody mix was
then tested for reactivity in an ELISA [52].
Immunoprecipitation and western blots
Parasite nuclear protein extract was prepared by high
salt. The nuclear extract was further diluted, pre-cleared
and incubated with RNAPII antibodies overnight at 4°C.
Protein complexes were precipitated by incubating with
Protein G agarose slurry for 1 h at 4°C followed by ex-
tensive washings to reduce the background. Protein
complexes were eluted by addition of SDS-PAGE load-
ing buffer and boiling for 5 min at 95°C. Supernatants
were resolved in 6% SDS-PAGE and subsequently used
for Western blot analysis. Western blots were carried out
using antibodies raised against the CTD of RNAPII described
in this study and the anti-CTD antibody 8WG16 (Covance)
[39]. Secondary antibody (anti-mouse-HRP, Sigma) was
visualized using a chemiluminescence detection system
(Millipore) as per the manufacturer’s instructions.
Mass spectrometry
Briefly, after immunoprecipitation, the eluent was sepa-
rated on a SDS-PAGE gel, and silver stained. The gel lane
was cut into 5 slices and then processed by a standard in-
gel digestion protocol using trypsin. Extracted tryptic pep-
tides of each slice was injected into a LC-MS/MS system
(LTQFT Ultra, Thermo Scientific, Bremen, Germany) for
peptide sequencing using tandem MS. The MS/MS spec-
tra of the raw data was extracted and converted into dta
files using extract_msn and then combined into a mascot
generic file using an in-house program as previously de-
scribed [53].
The P. falciparum protein database (5491 sequences,
4147970 residues) was used for database searches [54].
The database search was performed using an in-house
Mascot server (version 2.4.1, Matrix Science, Boston,
MA, USA) with MS tolerance of 10 ppm and MS/MS tol-
erance of 0.8 Da. Two missed cleavage sites of trypsin
were allowed. Carbamidomethylation (C) was set as a fixed
modification, and oxidation (M), and deamidation (N
and Q) were set as variable modifications. The obtained
peptide/protein list for each fraction was exported to Micro-
soft Excel or processed using an in-house script for further
analysis. Proteins PF3D7_0318200 (PFC0805w; RPB1),
PF3D7_0215700 (PFB0715w; RPB2) and PF3D7_0923000
(PFI1130c; RPB3) were positively identified in αSer5-P
and αSer2/5-P pull down samples but not with an IgG
control antibody. The Mascot results in Excel are provided
in Additional file 1: Table S1.
Parasite culture
Plasmodium falciparum T996 strain parasites were cul-
tured as described previously [55]. Highly synchronousparasites were grown at hematocrit of 2% and 5% para-
sitemia. For ChIP, saponin-lysed parasites were cross-
linked with 0.5% formaldehyde and harvested at 8, 16,
24, 32, 40 and 48 hpi. Samples were also taken for RNA
isolation from the same time points.
Chromatin immunoprecipitation
The chromatin immunoprecipitation assay was performed
as described [19]. Briefly, parasites were lysed by 200
strokes using a dounce homogenizer and centrifuged. The
nuclear pellet was lysed using 1% SDS and the resulting
nuclear extract was sheared in Vibra Cell sonifier at 25%
amplitude (10 sec on, 50 sec off) for 8 pulses to obtain
DNA fragments in the range of 200-1000 bp. The chro-
matin DNA was diluted, pre-cleared and incubated with
the immunoprecipitating antibody overnight at 4°C.
RNAPII-antibody-bound complexes were then bound to
salmon sperm DNA/Protein A agarose slurry for 1 h at
4°C, followed by extensive washings to reduce the back-
ground. Precipitated complexes were eluted from the
beads and the protein-DNA cross-links were reversed by
heating samples at 65°C overnight in 0.2 M NaCl. DNA
was purified using the QIAEX II kit (QIAGEN). Immuno-
precipitated DNA and the sonicated genomic DNA (input)
were amplified as described [56] with some modifications
[57]. Amplified ChIP and input DNA were labeled with
Cy5 and Cy3 respectively.
RNA preparation
For transcriptional profiling by microarray total RNA
from all the six time points was isolated using the Trizol
method and cDNA was synthesized by reverse transcrip-
tion, purified and labeled as previously described [1].
Samples for individual time points (labeled with Cy5, red)
were hybridized against a reference pool (labeled with
Cy3, green) which consisted of a mixture of RNA from all
the six time points in equal amounts.
Microarray hybridization and data analysis
Equal amounts of Cy5 and Cy3 labeled probes were used
to probe the microarrays representing the P. falciparum
genome. These microarrays consisted of14,981 probes,
containing 3895 50-mer intergenic oligonucleotide probes
and 10,566 70-mer ORF probes covering most of the 5,283
protein-coding genes [20]. On average, probes were spaced
every 1,502 bp along the length of most genes as annotated
in the P. falciparum genomic database (PlasmoDB) [19].
The microarray hybridization was carried at 63.5°C or
65°C in an automated hybridization station (Maui, USA)
for ChIP DNA or cDNA respectively as described previ-
ously [1]. The microarrays were scanned using the GenePix
scanner 400b and GenePix pro 6.0 software (Axon
Laboratory). The microarray data were normalized using
the Limma package of R [58]. Briefly, lowess normalization
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ground correction (Edwards [58]) and followed by quan-
tile normalization [59] between arrays. Spots with negative
flags or with signal intensities less than 1.4 times the back-
ground for both Cy5 and Cy3 fluorescence were elimi-
nated. Then, log2 ratio of Cy5 and Cy3 were used to
present the RNAPII occupancies for each spot. After aver-
aging triplicates, only spots where the signal from ChIP
DNA was obtained in at least 2 experimental repeats and
in at least 2 consecutive time points were included in fur-
ther study. Next, missing values were estimated by Kth
nearest neighbor (KNN) imputation using the impute
package of R. The estimated values were less than 0.2% of
the total. For expression microarray, each gene profile was
represented by an expression value calculated as an aver-
age of all probes representing a particular gene. Phaseo-
grams for expression and ChIP data were generated by
fast Fourier transform method and probes/genes were
sorted according to phase from -π to π with the mean-
centered log2 ratios. To address the dynamic changes in
RNAPII occupancies during the IDC, values for the fold
change of RNAPII and a Student’s t-test p were assigned
to each spot based on comparing the triplicates of summit
and valley time points. Significantly oscillated profiles be-
tween the summit and valley time points were defined as
p <0.05 and fold change ≥1.5 across the IDC. For ChIP-
chip experiments using the monoclonal antibody 8WG16
exceptionally, microarrays were performed twice and only
signals showing ≥1.5 change across the IDC in both arrays
were included for analysis.
Pearson’s Correlation Coefficient (PCC or r) was cal-
culated between the RNAPII binding profile and their
corresponding mRNA profiles. To compare the distribu-
tion of RNAPII along the gene body on the chromosome,
histograms were plotted to display the binding positions
with 500 bp intervals from -2 kb to 5 kb around coding
start site (ATG). A goodness-of-fit test was performed
within each bin to calculate the probability of that region
being equally bound by RNAPII for different gene groups.
Regions with binding bias by group were assigned at
p <0.05 using a chi-square test.
PCC (or “r”) was calculated between the RNAPII bind-
ing profiles and corresponding histone mark profiles.
Modified skewness value (S) was also calculated to meas-
ure the asymmetry of correlation distribution. Strictly, a
negative S value indicates that the distribution is biased to-
ward a positive correlation. However, for convenience, we
have taken the negative of the S value such that a positive
S value now represents a distribution biased to a positive
correlation. Likewise, a negative S value now represents a
bias toward negative correlation.
To test how statistically significant the RNAPII levels cor-
related with a particular histone modification level across
IDC, we generated a random dataset which contained ~20 krandomly paired profiles of RNAPII and histone modifica-
tions and a two-sample Kolmogorov-Smirnov test was
applied to compare the observed correlations and the
randomized correlations. In addition, a two-sample
Kolmogorov-Smirnov test was also applied to each pair
of data to test whether the function of correlations be-
tween RNAPII occupancies and histone modifications was
less or greater than the function of similar correlations
after one time point shift forward or backward in RNAPII
profile. In addition, we used the degree of skewness (S) of
the PCC distributions as a means of identifying histone
marks with maximum probe density showing positive cor-
relation with RNAPII occupancy. We identified 5 histone
marks including H3K9ac, H3K56ac, H4ac4, H4K12ac and
H4K20me1 with p <0.0005 and S >0.05 and which showed
clear positive correlation with Ser2/5-P RNAPII binding.
Quantitative real time PCR
qRT-PCR experiments were performed on immunopre-
cipiated and input DNA using the SYBR Green PCR
master mix (Kappa SYBR Fast Master Mix) according to
manufacturer’s instructions. All reactions were run in
triplicate. Product-specific amplification was confirmed
by performing melting curves for each reaction. For each
gene the fold change across the time points was calcu-
lated by calculating the difference in the Ct value for
each time point.
Primers
All the primers used in the current study are listed
(Additional file 9: Table S2).
Data access
The microarray data files associated with this study have
been submitted to NCBI GEO with accession number
GSE57748.
Additional data files
The following additional data are available with the on-
line version of this paper. Additional file 2: Figure S1)
presents the phaseogram, hierarchical clustering and
correlations to mRNA levels for ChIP-chip data using
the commercial anti-CTD antibody 8WG16. Additional
file 3: Figure S2) is a hierarchical clustering of the microarray
data presented in Figure 2A. Additional file 4: Figure S3) is
a representative example of the chromosomal distribu-
tion of genes identified in this study that bind RNAPII ei-
ther early or late in the infectious cycle. Additional file 5:
Figure S4) is an analysis of the genomic features (gene
length, GC content, number of introns, first exon
length) in the four classes of genes identified in this study.
Additional file 6: Figure S5) shows the distribution of cor-
relation between the binding of the unmodified-CTD
form of RNAPII and the occupancy profiles of 13 histone
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binding. Additional file 7: Figure S6) shows the distribu-
tion of correlation between the binding of the Ser5-P form
of RNAPII and the occupancy profiles of 13 histone modi-
fications assessed before during and after RNAPII binding.
Additional file 8: Figure S7) shows the distribution of cor-
relation between the binding of the Ser2/5-P form of
RNAPII and the occupancy profiles of 13 histone modifi-
cations assessed before during and after RNAPII binding.
Additional file 1: Table S1) presents the Mascot results in
Excel for results obtained by mass spectrometry with
αSer5-P and αSer-2/5 antibodies. Additional file 9: Table S2)
is a list of the oligonucleotides used in this study.
Additional files
Additional file 1: Table S1. Mascot results in Excel format following
mass spectrometric analysis of peptides co-immunoprecipitated with
αSer5-P and αSer2/5-P antibodies. The MS/MS spectra of the raw data
was extracted and converted into data files using extract_msn and then
combined into a mascot generic file using an in-house program.
Additional file 2: Figure S1. Results of ChIP-chip analysis using the
commercial anti-CTD monoclonal antibody 8WG16. ChIP-chip was
performed in duplicate and only probes with signals showing a fold
change ≥1.5 across the life cycle in both experiments were included
for analysis. (A) Heat maps showing phaseogram and hierarchical
clustering of loci bound by RNAPII. (B) A comparable analysis to
those presented in Figure 3. Approximately one third of probes
bound by RNAPII are strongly positively correlated with mRNA levels
(r ≥0.4) while a distinct third is strongly negatively correlated (r≤ -0.4).
Additional file 3: Figure S2. A hierarchical clustering of the microarray
data presented in Figure 2A. A hierarchical clustering of log-transformed
ChIP/input ratio of RNAPII occupancy for those loci where RNAPII shows an
oscillating profile with p <0.05 and fold change ≥1.5 across the life cycle.
Additional file 4: Figure S3. A representative example of the
chromosomal distribution of genes identified in this study that bind
RNAPII either early or late in the infectious cycle. Chromosomal
projection of RNAPII Ser2/5-P occupancy for early and late gene groups
onto chromosomes 3 (MAL3) and 4 (MAL4). The vertical bars (green)
indicate probe position for each gene group. Gene clusters can be seen
in red, the results for a “late” cluster on chromosome 4 is shown. Vertical
bars denote the positions of late genes, and the bars in red indicate a
cluster of 6 such genes spanning a mere 30 kb (shown to scale and with
gene names and their transcriptional orientation in the bottom half of
the figure).
Additional file 5: Figure S4. An analysis of the genomic features (gene
length, GC content, number of introns, first exon length) in the four
classes of genes identified in this study. Distinct genomic properties of
early vs late genes. Box plots show the distribution of (A) gene length,
(B) percentage GC content, (C) intron length (intron/exon ratio) and
(D) length of the first exon for the early and late genes. 1, early/negative,
2, late/negative, 3, early/positive and 4, late/positive. p value for the two
group comparisons is calculated using Wilcoxon two-tailed test and the
p-value for the four group comparison is calculated using “Kruskal-Wallis test”.
Additional file 6: Figure S5. Distribution of correlation between the
binding of the unmodified-CTD form of RNAPII and the occupancy
profiles of 13 histone modifications assessed before during and after
RNAPII binding. Distribution of correlation between the binding of the
unmodified-CTD form of RNAPII and the occupancy profiles of 13 histone
modifications assessed at 8 h earlier (-8 h) or later (+8 h) than RNAPII
binding. PCC was calculated between RNAPII profiles for all the probes
with p <0.05 and ≥1.5 fold change and the corresponding histone mark
after one-time point shift. For example, RNAPII binding at T2 was correlated
to histone marks in place at T1 (-8 h) and T3 (+8 h). (A) Correlations withhistone H3 modifications. (B) Correlations with histone H4 modifications.
Correlation distributions were plotted as histograms for each histone
modification, with bins of PCC ranging from -1 to +1 on x-axis plotted
against the total number of probes falling into each bin on the y-axis. A
two-sample Kolmogorov-Smirnov test was applied to each pair of data to
test whether the function of correlations between RNAPII occupancies and
histone modifications was less or greater than the function of similar
correlations after one time point shift forward or backward in RNAPII
profile. The statistical significance (p) of the correlation after the shift can
be seen at the bottom of each graph. Control: correlations between RNAPII
binding and histone modification within a single time point (e.g. T2). Shift
HM -8 h: Comparison of RNAPII binding to histone modification (HM) in
place 8 hours earlier. Shift HM +8 h: Comparison of RNAPII binding to
histone modification (HM) in place 8 hours later.
Additional file 7: Figure S6. Distribution of correlation between the
binding of the Ser5-P form of RNAPII and the occupancy profiles of 13
histone modifications assessed before during and after RNAPII binding.
Distribution of correlation between the binding of the Ser5-P form of
RNAPII and the occupancy profiles of 13 histone modifications assessed
at 8 h earlier (-8 h) or later (+8 h) than RNAPII binding. PCC was calculated
between RNAPII profiles for all the probes with p <0.05 and ≥1.5 fold
change and the corresponding histone mark after one-time point shift. For
example, RNAPII binding at T2 was correlated to histone marks in place
at T1 (-8 h) and T3 (+8 h). (A) Correlations with histone H3 modifications.
(B) Correlations with histone H4 modifications. Correlation distributions
were plotted as histograms for each histone modification, with bins of PCC
ranging from -1 to +1 on x-axis plotted against the total number of probes
falling into each bin on the y-axis. A two-sample Kolmogorov-Smirnov test
was applied to each pair of data to test whether the function of correlations
between RNAPII occupancies and histone modifications was less or greater
than the function of similar correlations after one time point shift forward or
backward in RNAPII profile. The statistical significance (p) of the correlation
after the shift can be seen at the bottom of each graph. Control: correlations
between RNAPII binding and histone modification within a single time
point (e.g. T2). Shift HM -8 h: Comparison of RNAPII binding to histone
modification (HM) in place 8 hours earlier. Shift HM +8 h: Comparison of
RNAPII binding to histone modification (HM) in place 8 hours later.
Additional file 8: Figure S7. Distribution of correlation between the
binding of the Ser2/5-P form of RNAPII and the occupancy profiles of 13
histone modifications assessed before during and after RNAPII binding.
Distribution of correlation between the binding of the Ser2/5-P form of
RNAPII and the occupancy profiles of 13 histone modifications assessed at
8 h earlier (-8 h) or later (+8 h) than RNAPII binding. PCC was calculated
between RNAPII profiles for all the probes with p <0.05 and ≥1.5 fold
change and the corresponding histone mark after one-time point shift. For
example, RNAPII binding at T2 was correlated to histone marks in place at
T1 (-8 h) and T3 (+8 h). (A) Correlations with histone H3 modifications.
(B) Correlations with histone H4 modifications. Correlation distributions
were plotted as histograms for each histone modification, with bins of PCC
ranging from -1 to +1 on x-axis plotted against the total number of probes
falling into each bin on the y-axis. A two-sample Kolmogorov-Smirnov test
was applied to each pair of data to test whether the function of correlations
between RNAPII occupancies and histone modifications was less or greater
than the function of similar correlations after one time point shift forward or
backward in RNAPII profile. The statistical significance (p) of the correlation
after the shift can be seen at the bottom of each graph. Control: correlations
between RNAPII binding and histone modification within a single time
point (e.g. T2). Shift HM -8 h: Comparison of RNAPII binding to histone
modification (HM) in place 8 hours earlier. Shift HM +8 h: Comparison of
RNAPII binding to histone modification (HM) in place 8 hours later.
Additional file 9: Table S2. Oligonucleotides used in this study.Abbreviations
ac: Acetyl; bp: Base pair (s); ChIP: Chromatin immunoprecipitation; CTD:
C-terminal domain; GO: Gene Ontology; H3: Histone 3; H4: Histone 4;
hpi: Hours post-infection; IDC: Intraerythrocytic developmental cycle; kb:
Kilo-base-pair (s); KEGG: Kyoto Encyclopedia of Genes and Genomes;
KNN: Kth nearest neighbor; me: Methyl; MPMP: Malaria Parasite Metabolic
Pathway; PCC: Pearson’s Correlation Coefficient; RNAPII: RNA polymerase II;
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